Epithelial and microbial determinants of colonic drug distribution.
Barrier
Colon
Distribution
Epithelium
Intracellular
Microbes
Journal
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982
Informations de publication
Date de publication:
01 Apr 2023
01 Apr 2023
Historique:
received:
31
10
2022
revised:
18
01
2023
accepted:
19
01
2023
pubmed:
24
1
2023
medline:
3
3
2023
entrez:
23
1
2023
Statut:
ppublish
Résumé
A dynamic epithelium and a rich microbiota, separated by multi-layered mucus, make up the complex colonic cellular environment. Both cellular systems are characterized by high inter- and intraindividual differences, but their impact on drug distribution and efficacy remains incompletely understood. This research gap is pressing, as, e.g., inflammatory disorders of the colon are on the rise globally. In an effort to help close this gap, we provide considerations on determining colonic epithelial and microbial cellular parameters, and their impact on drug bioavailability. First, we cover the major cell types found in vivo within the epithelium and microbiota, and discuss how they can be modeled in vitro. We then draw attention to their structural similarities and differences with regard to determinants of drug distribution. Once a drug is solubilized in the luminal fluids, there are two main classes of such determinants: 1) binding processes, and 2) transporters and drug-metabolizing enzymes. Binding lowers the unbound intracellular fraction (f
Identifiants
pubmed: 36690119
pii: S0928-0987(23)00020-9
doi: 10.1016/j.ejps.2023.106389
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Membrane Transport Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106389Informations de copyright
Copyright © 2023. Published by Elsevier B.V.